StockData
Trinity Biotech PLC logo

Trinity Biotech PLC (TRIB) stock

TRIBNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 30, 2026Score 1/30
$6.01+0.63 (+11.81%)

Close on Nov 17, 2026Market cap $112.45MP/E –Yield –

Trinity Biotech cash

Cash and short-term investments held at the end of each period.

Trinity Biotech's cash was $5.14M at Dec 31, 2025. For fiscal 2025 it was $5.14M, down 0.6% from the year before. Over ten years it grew -25.8% a year on average. The highest annual figure on record is $101.95M in fiscal 2015.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$5.14M-0.6%
FY2024Dec 31, 2024$5.17M+40.0%
FY2023Dec 31, 2023$3.69M-43.9%
FY2022Dec 31, 2022$6.58M-74.6%
FY2021Dec 31, 2021$25.91M-5.2%
FY2020Dec 31, 2020$27.33M+79.4%
FY2019Dec 31, 2019$15.23M-49.7%
FY2018Dec 31, 2018$30.28M-47.4%
FY2017Dec 31, 2017$57.61M-25.3%
FY2016Dec 31, 2016$77.11M-24.4%
FY2015Dec 31, 2015$101.95M+1020.1%
FY2014Dec 31, 2014$9.10M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025$5.14M+39.2%
Q2 FY2025Jun 30, 2025$1.55M-76.5%
Q4 FY2024Dec 31, 2024$5.17M-50.6%
Q2 FY2024Jun 30, 2024$5.32M-79.5%
Q4 FY2023Dec 31, 2023$3.69M-86.5%
Q4 FY2022Dec 31, 2022$6.58M-56.8%
Q2 FY2022Jun 30, 2022$10.45M-65.5%
Q4 FY2021Dec 31, 2021$25.91M-47.6%
Q4 FY2020Dec 31, 2020$27.33M-49.3%
Q4 FY2019Dec 31, 2019$15.23M-73.6%
Q4 FY2018Dec 31, 2018$30.28M-52.7%
Q2 FY2018Jun 30, 2018$49.43M-29.2%
Q1 FY2018Mar 31, 2018$53.90M-30.1%
Q4 FY2017Dec 31, 2017$57.61M-43.5%
Q2 FY2017Jun 30, 2017$63.98M+602.9%
Q1 FY2017Mar 31, 2017$69.85M–
Q4 FY2016Dec 31, 2016$77.11M–
Q4 FY2015Dec 31, 2015$101.95M–
Q4 FY2014Dec 31, 2014$9.10M–

More Trinity Biotech figures

See a number that looks wrong?